Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Clinical & Experimental Ophthalmology|February 16, 2007
Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes studyDianne M Sharp, Susannah Lai, Caroline M MarkeyClinical & Experimental Ophthalmology|September 1, 2007
Reversible optic neuropathy due to metronidazoleNicole M McGrath, Brian Kent-Smith, Dianne M SharpOphthalmic Genetics|June 12, 2014
A novel rhodopsin point mutation, proline-170-histidine, associated with sectoral retinitis pigmentosaShaheen P Shah, Fulton Wong, Dianne M Sharp, et al.Clinical & Experimental Ophthalmology|April 6, 2005
Clinical manifestations of a unique X-linked retinal disorder in a large New Zealand family with a novel mutation in CACNA1F, the gene responsible for CSNB2Carolyn I Hope, Dianne M Sharp, Ariana Hemara-Wahanui, et al.BMJ (Clinical Research Ed.)|September 27, 2005
Randomised controlled trial of prevention of falls in people aged > or =75 with severe visual impairment: the VIP trialA John Campbell, M Clare Robertson, Steven J La Grow, et al.Investigative Ophthalmology & Visual Science|April 24, 2009
Transient retinal effects of 5,6-dimethylxanthenone-4-acetic acid (DMXAA, ASA404), an antitumor vascular-disrupting agent in phase I clinical trialsMichael B Jameson, Dianne M Sharp, Jennifer I Sissingh, et al.Proceedings of the National Academy of Sciences of the United States of America|May 18, 2005
A CACNA1F mutation identified in an X-linked retinal disorder shifts the voltage dependence of Cav1.4 channel activationAriana Hemara-Wahanui, Stanislav Berjukow, Carolyn I Hope, et al.Pageof 1